VAscular Closure for Cardiac Ablation Registry (VACCAR)

NCT03546439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 434

Last updated 2022-03-11

Study results available
· View outcomes & findings →

Summary

The objective of this registry is to find out if there is a difference in patient satisfaction and rate of vascular and bleeding complications with use of Perclose Proglide system or F08S for venous closure post atrial fibrillation and atrial flutter procedures in comparison to manual compression.

Conditions

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY
  • Saint Luke's Health System

    lead OTHER

Principal Investigators

  • Sanjaya Gupta, MD · Saint Luke's Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-25
Primary Completion
2019-05-24
Completion
2019-05-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03546439 on ClinicalTrials.gov